Published • loading... • Updated
Abram Scientific Awarded Up To $8.3 Million under a DARPA Contract to Advance Rapid, Portable Blood Coagulation Diagnostics for Trauma Care
Summary by soldiersystems.net
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Abram Scientific Awarded Up To $8.3 Million under a DARPA Contract to Advance Rapid, Portable Blood Coagulation Diagnostics for Trauma Care
MENLO PARK, Calif., Oct. 13, 2026 — Abram Scientific, a medical device company focused on advancing next-generation coagulation diagnostics, today announced that it has been awarded a contract of up to $8.3 million from the Defense Advanced Research Projects Agency (DARPA) to advance its rapid, handheld blood coagulation testing platform CoagCare™ for use in trauma settings. […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
